Autoimmune retinopathy in the absence of cancer.

[1]  G. Adamus,et al.  Epitope recognition of recoverin in cancer associated retinopathy: Evidence for calcium‐dependent conformational epitopes , 1996, Journal of neuroscience research.

[2]  J. Flannery,et al.  The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. , 1996, Clinical immunology and immunopathology.

[3]  L. Baizer,et al.  Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Adamus,et al.  Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. , 1994, Experimental eye research.

[5]  P. Hargrave,et al.  Role of anti-recoverin autoantibodies in cancer-associated retinopathy. , 1993, Investigative ophthalmology & visual science.

[6]  A. Roth,et al.  Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. , 1993, Archives of ophthalmology.

[7]  Y. Tamaki,et al.  A case of paraneoplastic retinopathy. , 1993, Japanese journal of ophthalmology.

[8]  S. Jacobson,et al.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. , 1993, Investigative ophthalmology & visual science.

[9]  J. Tiedeman,et al.  Hemeralopia in an older adult. , 1992, Survey of ophthalmology.

[10]  A. Roth,et al.  The cancer-associated retinopathy antigen is a recoverin-like protein. , 1992, Investigative ophthalmology & visual science.

[11]  J. Rizzo,et al.  Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. , 1992, Ophthalmology.

[12]  G. Fishman,et al.  'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. , 1992, Investigative ophthalmology & visual science.

[13]  W. Riley.  Autoimmune polyglandular syndromes. , 1992, Hormone research.

[14]  A. Roth,et al.  Management and monitoring of cancer-associated retinopathy. , 1992, Archives of ophthalmology.

[15]  M. Nakagawa,et al.  Antibodies against human retinal proteins in serum from patients with cone dystrophy. , 1992, Japanese journal of ophthalmology.

[16]  N. Maclaren,et al.  Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. , 1991, Endocrinology and metabolism clinics of North America.

[17]  A. Roth,et al.  Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. , 1991, American journal of ophthalmology.

[18]  M. Tso,et al.  Antiretinal antibodies in serum of patients with age-related macular degeneration. , 1991, Ophthalmology.

[19]  K. Palczewski,et al.  A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy , 1991, The Journal of cell biology.

[20]  S. Tipping,et al.  A clinical triad to diagnose paraneoplastic retinopathy , 1990, Annals of neurology.

[21]  A. Roth,et al.  Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. , 1989, The New England journal of medicine.

[22]  M. Marmor,et al.  Standard for Clinical Electroretinography: International Standardization Committee , 1989 .

[23]  M. Rosenblum,et al.  Autoantibodies in paraneoplastic syndromes associated with small‐cell lung cancer , 1988, Neurology.

[24]  E. Berson,et al.  Paraneoplastic night blindness with malignant melanoma. , 1988, American journal of ophthalmology.

[25]  Crofts Jw,et al.  Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. , 1988 .

[26]  J. Towfighi,et al.  Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells , 1987, Cancer.

[27]  A. Roth,et al.  Cancer-associated retinopathy. , 1987, Archives of ophthalmology.

[28]  J. Cunningham,et al.  Autoimmune pathogenesis of paraneoplastic neurological syndromes. , 1987, Critical reviews in neurobiology.

[29]  S. Kornguth,et al.  Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. , 1986, Cancer research.

[30]  J. Heckenlively,et al.  Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings. , 1985, The British journal of ophthalmology.

[31]  S. Kornguth,et al.  AUTOIMMUNE BASIS FOR VISUAL PARANEOPLASTIC SYNDROME IN PATIENTS WITH SMALL-CELL LUNG CARCINOMA , 1985, The Lancet.

[32]  J. Heckenlively,et al.  Autoimmunity in hereditary retinal degeneration. I. Basic studies. , 1985, The British journal of ophthalmology.

[33]  R. Carr,et al.  Functional abnormalities in vincristine-induced night blindness. , 1984, Investigative ophthalmology & visual science.

[34]  D. Archer,et al.  An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. , 1984, American journal of ophthalmology.

[35]  M. Kumar,et al.  Role of autoimmunity in retinitis pigmentosa. , 1983, Annals of ophthalmology.

[36]  A. Roth,et al.  Photoreceptor degeneration. Possible autoimmune disorder. , 1983, Archives of ophthalmology.

[37]  S. Kornguth,et al.  Occurrence of anti‐retinal ganglion cell antibodies in patients with small cell carcinoma of the lung , 1982, Cancer.

[38]  W. Hoyt,et al.  Blindness caused by photoreceptor degeneration as a remote effect of cancer. , 1976, American journal of ophthalmology.